The Latest Cancer Drugs News
Browsing: Cancer Drug News
Protected: Novel triplet therapy for newly diagnosed multiple myeloma patients now TGA approved
This content is password protected. To view it please enter your password below: Password:
A liquid biopsy test can identify patients who may respond to immune checkpoint blockade
A new liquid biopsy test could detect microsatellite instability (MSI) and tumour mutational burden (TMB),…
Researchers warn that cancer drugs don’t always work as intended
Scientists at Cold Spring Harbor Laboratory (CSHL) have identified 10 cancer drugs currently in clinical…
Breaking the ‘stalemate’ in the most common soft tissue sarcoma in children
A phase 2 clinical trial has found that combining a molecular targeted drug called temsirolimus…
Risks of novel oral prostate cancer therapies and pre-existing conditions
A new large population-based study shows that novel oral androgen signalling inhibitor therapies are associated…
New hope for aggressive breast cancers as diabetes drug creates treatment ‘sweet spot’
A drug commonly used to treat Type 2 diabetes can force breast cancer ‘stem cells’…
A homing beacon for chemotherapy drugs
Killing tumour cells while sparing their normal counterparts is a central challenge of cancer chemotherapy.…
Study reports ibrutinib and venetoclax combo effective as front-line therapy for select chronic lymphocytic leukemia patients
Ibrutinib and venetoclax, two FDA-approved drugs for treating chronic lymphocytic leukemia (CLL), have been shown…
World’s first ‘Darwinian’ cancer drug programme aims to deliver step change in cancer treatment
The world’s first ‘Darwinian’ drug discovery programme specially designed to tackle cancer’s lethal ability to…
Children with cancer wait an average of 6.5 years longer than adults to access new drugs
Cancer drugs approved by the U.S. Food and Drug Administration (FDA) took a median of…